|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage. |
| Contraception. 2004 Mar;69(3):197-199. |
| We investigated the effect of tampon co-usage on systemic exposure to etonogestrel (ENG) and ethinylestradiol (EE) |
| from the combined contraceptive vaginal ring, NuvaRing. One cycle of ring use consists of 3 weeks of ring use |
| followed by a 1-week ring-free period. Fourteen healthy women were randomized to use both NuvaRing and tampons |
| (Kotex regular) or NuvaRing alone for one cycle; participants then switched to the alternate treatment regimen for a |
| second cycle of ring use. The first tampon was self-administered on day 8 of the interaction cycle; 4 tampons a day |
| were used for 3 consecutive days. Tampon co-usage did not result in any changes in serum ENG or EE |
| concentrations and is thus not expected to compromise the ring's contraceptive efficacy. (PubHealth.info Document |
| PubHealth.info NOTE: The author(s) of this article titled, "The combined contraceptive vaginal ring, NuvaRing, and |
| tampon co-usage.", is(are) Verhoeven CH; Dieben TO. The source of this article is "Contraception. 2004 |
| Mar;69(3):197-199.". This article was published in 2004 in English language(s). (PubHealth.info® Document ID: |
| CONT1T 502-06. All rights reserved with PubHealth.info) PIN: 502 |
| This article is peer-reviewed. |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |